StartUp Health NOW Podcast · StartUp Health NOW Podcast

How Veravas Brings Clarity to Diagnostics by Cleaning Samples

·31 min·3 clips

Logan Plaster reveals how blood tests can fail when you're sick, leading to false results that impact your health decisions.

This episode of StartUp Health NOW features host Logan Plaster interviewing John Forrest, CEO and co-founder of Veravas, a company focused on improving diagnostic test accuracy. The conversation centers on the often-overlooked problem of unreliable blood and saliva test results, especially for serious illnesses. Forrest explains that biological samples contain many interfering substances that compromise test precision. Veravas has developed and patented a technology called Veribind, which functions to clean blood samples by removing impurities. This process aims to convert tests with ambiguous ranges or false results into clear yes-or-no diagnostics. The company is initially applying Veribind to improve the detection of Alzheimer's disease. The technology is described as a platform, meaning its potential applications extend beyond a single condition. Forrest details that the technology could enhance the accuracy of a wide array of diagnostic tests. Its utility is not limited to blood samples; it can also be applied to saliva, which is easier for older populations to provide regularly. The core argument is that sample impurities are a major, unaddressed source of diagnostic error. By tackling this pre-analytical variable, Veravas seeks to bring greater clarity to lab results. A key insight is that diagnostic inaccuracy is often a problem with the sample matrix itself, not just the test's analytical method. The discussion implies that cleaning the sample could reduce costly false positives and anxiety-inducing gray-zone results. Forrest's background in health tech lends weight to his perspective on the diagnostic industry's challenges. The episode suggests that improving foundational sample quality could be a more scalable solution than refining individual assays. The tone is educational and conversational, framed as a discovery interview with an innovative entrepreneur. The style is explanatory, breaking down a complex technical problem for a general audience interested in health innovation. Listeners interested in medical technology, diagnostic science, or startup solutions in healthcare would find this episode compelling. Those seeking clinical deep-dives or patient narratives might find the focus on proprietary technology and sample processing too niche.

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from StartUp Health NOW Podcast